Cargando…
Regenerative technologies to bed side: Evolving the regulatory framework
There are high expectations for the clinical application of regenerative medicine technologies to treat musculoskeletal disorders. However, there are still big hurdles in bringing cell-based products to the market, mainly due to strict regulatory frameworks to approve these. Recently, the Japanese P...
Autores principales: | Sakai, Daisuke, Schol, Jordy, Foldager, Casper B., Sato, Masato, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822969/ https://www.ncbi.nlm.nih.gov/pubmed/29662794 http://dx.doi.org/10.1016/j.jot.2017.02.001 |
Ejemplares similares
-
Corrigendum to ‘Regenerative technologies to bed side: Evolving the regulatory’ [J Orthop Translat 9 (2017) 1–7]
por: Sakai, Daisuke, et al.
Publicado: (2018) -
Clinical Development of Regenerative Medicine Targeted for Intervertebral Disc Disease
por: Sakai, Daisuke, et al.
Publicado: (2022) -
Annulus fibrosus cell sheets limit disc degeneration in a rat annulus fibrosus injury model
por: Nukaga, Tadashi, et al.
Publicado: (2019) -
Rubinstein-Taybi syndrome with scoliosis treated with single-stage posterior spinal fusion: illustrative case
por: Imai, Takeshi, et al.
Publicado: (2021) -
Effect of Whole Tissue Culture and Basic Fibroblast Growth Factor on Maintenance of Tie2 Molecule Expression in Human Nucleus Pulposus Cells
por: Sako, Kosuke, et al.
Publicado: (2021)